G2TT
来源类型Report
规范类型报告
DOIhttps://doi.org/10.7249/RR2108
来源IDRR-2108-OSD
Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes: A Systematic Review
Margaret A. Maglione; Laura Raaen; Christine Chen; Gulrez Shah Azhar; Nima Shahidinia; Mimi Shen; Ervant J. Maksabedian Hernandez; Roberta M. Shanman; Susanne Hempel
发表日期2018-10-30
出版年2018
页码273
语种英语
结论

A comprehensive literature search that screened over 6,000 research citations on the topic identified only 27 randomized controlled trials and ten observational studies that reported on functional outcomes

  • No randomized control trial was rated as high quality, but several observational studies were methodologically sound.
  • The only functional measures reported in more than one study were verbal memory, attention, insomnia, fatigue, and criminal activity.
  • MAT users had twice the risk of injurious traffic accidents than nonusers, according to one large observational study.
  • Based on two studies, it appears that MAT users do not perform worse on verbal memory tasks than healthy controls.
  • One study showed that patients taking buprenorphine or methadone scored higher in aggressive responding than healthy controls.

Evidence was mixed when MAT patients were compared with persons with OUD who were not on MAT

  • One cohort comparison found that fewer buprenorphine patients reported fatigue than did persons with OUD who did not receive MAT; other physical and behavioral/social function outcomes had mixed findings or showed no differences.

There was little statistically robust evidence that treatment effects systematically vary by medication

  • A comparison across randomized controlled trials found a significantly lower prevalence of fatigue in buprenorphine patients compared with methadone patients.

Direct comparisons of functional effects by route of administration, length of treatment, and treatment modality were scarce and reported mixed results and pointed to important research gaps that should be addressed in future studies

摘要

This systematic review addresses the question: What are the effects of medication-assisted treatment (MAT) that use buprenorphine, buprenorphine combined with naloxone, methadone, or naltrexone for opioid use disorder (OUD) on functional outcomes compared with wait-list, placebo, treatment without medication, any other comparator, or each other (e.g., buprenorphine versus naltrexone)?

,

Functional outcomes investigated included cognitive (e.g., memory), physical (e.g., fatigue), occupational (e.g., employment status), social/behavioral (e.g., criminal activity), and neurological (e.g., balance) function.

,

We searched five scientific research databases from inception to 2017 and reference mined existing reviews. Two independent literature reviewers screened 6,292 citations; 1,327 full-text publications were reviewed in detail and 37 studies met inclusion criteria. Critical appraisals assessed studies in detail, and quality of evidence was rated using established criteria. Results were synthesized in meta-analyses and presented in comprehensive evidence tables. Although MAT patients performed significantly better on some functional outcomes than persons with OUD who did not receive MAT, MAT patients performed worse on several cognitive measures than did matched "healthy" controls with no history of substance use disorder (SUD) or OUD. Because of the moderate-to-high risk of bias of most studies, quality of evidence is low or very low for all findings.

,

The small number of studies reporting on outcomes of interest and the weaknesses in the body of evidence prevent making strong conclusions about MAT effects on functional outcomes. The literature shows that more research is needed that targets functional outcomes specifically, and there is, in particular, a lack of research evaluating potential differences in functional effects among medication types, the route of administration, treatment modality, and length of treatment.

目录
  • Chapter One

    Introduction

  • Chapter Two

    Methods

  • Chapter Three

    Results

  • Chapter Four

    Discussion

  • Appendix A

    Food and Drug Administration Warnings Table

  • Appendix B

    Search Methodology

  • Appendix C

    Risk of Bias Instruments

  • Appendix D

    Evidence Table

  • Appendix E

    Excluded Publications

主题Military Health and Health Care ; Opioids ; Pharmaceutical Drugs ; Substance Use Disorder Treatment
URLhttps://www.rand.org/pubs/research_reports/RR2108.html
来源智库RAND Corporation (United States)
引用统计
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/523663
推荐引用方式
GB/T 7714
Margaret A. Maglione,Laura Raaen,Christine Chen,et al. Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes: A Systematic Review. 2018.
条目包含的文件
文件名称/大小 资源类型 版本类型 开放类型 使用许可
RAND_RR2108.pdf(3003KB)智库出版物 限制开放CC BY-NC-SA浏览
1543953178071.jpg(6KB)智库出版物 限制开放CC BY-NC-SA缩略图
浏览
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Margaret A. Maglione]的文章
[Laura Raaen]的文章
[Christine Chen]的文章
百度学术
百度学术中相似的文章
[Margaret A. Maglione]的文章
[Laura Raaen]的文章
[Christine Chen]的文章
必应学术
必应学术中相似的文章
[Margaret A. Maglione]的文章
[Laura Raaen]的文章
[Christine Chen]的文章
相关权益政策
暂无数据
收藏/分享
文件名: RAND_RR2108.pdf
格式: Adobe PDF
文件名: 1543953178071.jpg
格式: JPEG

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。